MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Viroptic

Company: King Pharmaceuticals
Approval Status: Approved February 1998
Treatment for: inflammation of the cornea due to herpes simplex virus
Areas: Immune System; Eye Health / Ophthalmology; Pediatrics

| General Information |


General Information

Viroptic Oththalmic Solution (trifluridine) 1% has been approved for use in children (ages 6+) as a treatment for inflammation of the cornea caused by the herpes simplex virus. The antiviral agent was previously approved for use in adults.




< back to top

Viroptic Drug Information

The Viroptic drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.